ONLY oral unit-dose warfarin, prefilled Fragmin syringes, and premixed heparin drips are used at CHSB.

Slides:



Advertisements
Similar presentations
NPR REPORTS, RULES AND MEDICATION SAFETY
Advertisements

Warfarin (Coumadin® / Jantoven®)
National Patient Safety Goal 3E:
ANTICOAGULANT THERAPY REVISITED 2004 or, Which one(s) of these drugs should be the one(s) I use, and for what?
Advanced Adult Intravenous Calculations
Advanced Adult Intravenous Calculations
Unique Anticoagulation Issues at University Hospitals Case Medical Center Teresa L. Carman, MD Director, Vascular Medicine Case Medical Center Pager
Vanderbilt Pediatric Hematology Anticoagulation Guidance Protocol Robert F. Sidonio, Jr. MD, MSc. 4/11/12 Enoxaparin Dosing Goal anti-Xa levels are 0.6.
 Knowledge of the commonly used anticoagulant drugs is important in reducing the likelihood of patient harm associated with their administration.  Common.
Chapter Six Venous Disease Coalition Acute Management of VTE VTE Toolkit.
Warfarin Sodium (Anticoagulant) Therapy Training 03/10/2015.
DR DIPTI CHITNAVIS HAEMATOLOGY CONSULTANT WEST SUFFOLK HOSPITAL JANUARY 2014 Update on the new oral anticoagulants; 12 months on.
Best Practices in Meeting NPSG 3E-Anticoagulation Requirements MaryAnne Cronin, PharmD Assistant Director of Pharmacy Glen Cove Hospital.
Developed by Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed : October 2009 Most recently updated: September 2013.
Preventing Anticoagulation Errors with Clinical Dashboards Dan Johnson, Pharm.D., BCPS August 3, 2011.
Treating Stroke With Drug Therapies Michael Faithe, Pharm.D., BCPS Neurosciences Clinical Pharmacy Specialist University of Colorado Hospital.
Goal Of Project To reduce adverse outcomes of warfarin therapy by developing and implementing an inpatient warfarin dosing protocol, and by instituting.
Anticoagulation Safety: Meeting the Challenge of the National Patient Safety Goal 3E Larry Clark, PharmD, MS, BCPS Director of Pharmacy Thomas, McCloskey,
NURS 1950 Pharmacology I 1.  Objective 1: identify general reasons anticoagulants are given 2.
Warfarin and Dietary Interactions: Developing a Food and Drug Interaction Program Rehana Jamali, Pharm.D. Associate Director, Pharmacy Services Brookdale.
Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed: June, 2012 Most recent update: October 2013 Venous Thromboembolism (VTE) Measure.
Vanderbilt Pediatric Hematology Anticoagulation Guidance Protocol Robert F. Sidonio, Jr. MD, MSc. 4/12/12 Warfarin Monitoring If inpatient, consider monitoring.
Total Joint Replacement
 Schedule I – Only w/ approved protocol ▪ Heroin, marijuana  Schedule II – Written rx only, no refills ▪ Codeine, morphine, methadone, oxycontin, ritalin,
The Clinical Guide “A Guide to Implementing Renal Best Practice in Haemodialysis“ Chapter 5: Anticoagulation Team Leader: Angela Henson Co-authors: Franta.
DVT Prevention and Anticoagulant Management
Anticoagulations and Coagulants
Core Measures 2014 Revised 11/30/13.
Management of Patients Taking Anticoagulants Darwin Deen, MD, MS.
Anticoagulation ACCP guidelines 2012
Peri-Operative anticoagulation /antiplatelet therapy A Shift in Paradigm BMHGT04/29/09.
Clinical Note Writing Pharmacy Department Dale Tucker, RPh, BCPS Elizabeth Cincotta, PharmD Detroit Medical Center Last Updated July 2005 by Julie Berman.
Agents Affecting Blood Clotting
Coagulation Modifier Agents Lilley Pharmacology Text: Chapter 26 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed. Professor of Nursing Original.
Chapter 19 Agents affecting Blood Clotting. Blood Clotting p461 Clotting is necessary to prevent fatal loss of blood from a minor injury Thromboemboli.
DVT cases.  Heparin, low molecular weight heparin, or fondaparinux are usually continued for at least five days, along with another medication called.
Dr. Ryan Clark, DO Grandview Medical Center, Dayton, OH NOVEL ORAL ANTICOAGULANTS.
Non-vitamin K antagonist oral anticoagulants (NOACs)
Spotlight Case Watch the Warfarin!. 2 Source and Credits This presentation is based on the July 2011 AHRQ WebM&M Spotlight Case –See the full article.
Warfarin Therapy Aaqid Akram MBChB (2013) Clinical Education Fellow.
Non-vitamin K antagonist oral anticoagulants (NOACs) YOUR FACILITY Presenter Month YYYY September 2016 Version 2.
Blood/Blood Formation
Anticoagulants, Antiplatelets, and Thrombolytics
Minimizing risk and Optimizing Safety
Warfarin Toxicity Treatment & Management
Anticoagulants and Antiplatelets
Anticoagulants in the Treatment of Venous Thromboembolism
Heparin Infusion Calculations
Heparin Drips “Heparin Dose Documentation”
Management of Direct Oral Anticoagulants
Ortho Warfarin Dosing Protocol
Use of NOACs is contraindicated for AF patients with mechanical prosthetic valves or moderate- severe mitral stenosis (usually of rheumatic origin). Although.
Anticoagulation Prepared by Cherie Gan.
Anticoagulation Therapy
Module 3 REDUCE THE LIKELIHOOD OF PATIENT HARM ASSOCIATED WITH THE USE OF ANTICOAGULANT THERAPY.
Medication Safety & Anticoagulation
ADAS Anticoagulant Dosing and Advisory Service
Chapter 17 Hematologic Products
Dabigatran: Medication Use Evaluation
GHS Outpatient Enoxaparin Program
Anticoagulant Reversal
Periprocedural Management of Patients on Anticoagulation
Use of Medications Safely
ADAS Anticoagulant Dosing and Advisory Service
MOST Study Update and Protocol Refresher
Drug Summary Info Document Request / monitor Goal of therapy Action
Presentation transcript:

REDUCE THE LIKELIHOOD OF PATIENT HARM ASSOCIATED WITH THE USE OF ANTICOAGULANT THERAPY

ONLY oral unit-dose warfarin, prefilled Fragmin syringes, and premixed heparin drips are used at CHSB.

Use Approved Protocols CHSB Inpatient Anticoagulation Protocol Available on all units in the Pharmacy Protocol/Formulary Book Includes warfarin (Coumadin), heparin and LMWH (Fragmin) Defines roles of RPh, RN, and Dietician

Warfarin Pharmacy-dosed protocol Rx will monitor and dose all patients MUST check/document INR before 1st dose Rx will not dispense doses until INR available RN must document INR on eMAR prior to each dose Care Plan must be initiated & updated Monitor patient for bleeding Check INR Educate patient re: bleeding, safety precautions Education must be documented during admission and at discharge

Vitamin K reverses the effects of warfarin Food-Drug Interactions Vitamin K in foods Green, leafy vegetables spinach, collard greens, brussel sprouts, broccoli Cranberry juice Discharge Instructions Krames On Demand MUST include: Compliance and the importance of follow-up monitoring Potential for adverse drug reactions and interactions

Heparin NPSG includes therapeutic heparin Heparin flushes, prophylactic doses excluded MUST use premade heparin drips Do NOT mix a heparin drip MUST use the drug library on the infusion pumps when administering

Heparin Protocol Bolus Doses – use 1000 units/ml ONLY NEVER bolus from the infusion bag! Weight-based dosing Monitoring aPTT baseline every 6 hours after ANY dosage change 6 hours after first therapeutic aPTT every 24 hours after 2 consecutive aPTTs CBC with platelets Baseline every 3 days

Heparin Protocol Adjusting the rate: Recheck the aPTT in 6 hours aPTT <60: bolus dose and ↑ rate aPTT 60-90: NO ADJUSTMENT aPTT >90: hold drip and/or ↓ rate Recheck the aPTT in 6 hours Document all bolus doses and rate changes on eMAR Each bolus dose is documented on eMAR Any rate changes and each bag change are document on eMAR

Low-Molecular Weight Heparin (Fragmin) NPSG includes therapeutic doses Low-dose for DVT prophylaxis excluded Baseline labs required CBC with platelets

Pradaxa (dabigatran) Baseline laboratory tests: PT/INR SCr Ongoing laboratory tests: SCr every 7 days Pharmacy will adjust dose as needed for renal function

Xarelto (RIVAROXABAN) Baseline laboratory tests: CBC SCr Ongoing laboratory tests: SCr every 7 days Should be avoided in patients on dialysis Medication should not be crushed Give with food for better absorption

Patient Education Only Krames On-Demand will be used Coumadin (warfarin) Heparin Fragmin Pradaxa Xarelto